23 Mar US Trial Confirms Astrazeneca Vaccine As Safe And Highly Effective
According to the US trial results, AstraZeneca’s COVID-19 vaccine has been proved safe and 100% effective against severe infection inflicted by the Coronavirus. The efficiency analysis of this shot was published on Monday.
The reports clearly state that AstraZeneca Vaccine is 79% effective against symptomatic COVID-19 and 100% effective in preventing severe infections. Earlier, the administration of vaccine jabs was put on hold due to blood clots’ diagnosis in the people who received it.
In the phase 3 trial, the vaccine shots were tested on more than 30,000 volunteers from all over the world. The team monitored that no side effects were inflicted on a majority of participants. Rather, 76% efficiency was recorded after the first dos, which later increased to 82%.
The Phase 3 Trial resulted from the criticism expressed by various health experts that this vaccine is not safe and effective against the virus.
However, this trial claims some promising benefits of the Oxford-AstraZeneca Vaccine. It is also proven to prevent infection in people over the age of 65.
According to the studies, about one-fifth of the volunteers were above 65 and after receiving two doses, the vaccine provided the same protection as provided to younger age groups.
Moreover, the company also said that an independent board identified no safety hazards of the vaccine. Research was also conducted to check whether they cause blood clots under the guidance of an independent neurologist.
The results pointed out that the vaccine does not cause thrombosis, a severe blood clot in the brain, and is highly effective.
Several countries in the UK have already started vaccination drives for thousands of people.
Co-designer of the vaccine, Prof Sarah Gilbert, said that this vaccine is highly effective against COVID-19 and widespread use of AstraZeneca’s Vaccine can help bring this pandemic to an end.